Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc > Details...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by RockMaschineon Apr 01, 2021 3:27pm
203 Views
Post# 32924568

RE:RE:RE:Details...

RE:RE:RE:Details...
Seems to make sense that those who lost the most want to seal the deal and mark it zero. Nobody else is knocking on MYMs door and if you turn down this deal it is a certainty the company would be begging for money at 20% within a year.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities